MedWatch

Europe prepares a mutant Covid vaccine plan to fight the crisis

In an effort to get its inoculation drive on track, the European Union’s executive arm will vow to accelerate research, authorization, procurement and distribution for vaccines that fight variants of the coronavirus, while also asking member states for more money to back the drive.

Photo: Yves Herman/REUTERS / X00380

The European Commission wants to adapt existing contracts and strike new purchase agreements with pharmaceutical companies to secure shots that protect against Covid-19 mutations, according to a draft proposal of the strategy seen by Bloomberg. The contracts will include safeguards to avoid earlier missteps that tarnished the current vaccine rollout.

"Existing agreements may have to be updated to cover protection against variants," according to the plan, which will be published on Wednesday and could still be changed. "Based on the lessons learned, a detailed and credible plan showing capability to produce vaccines in the EU on a reliable timescale will be a prerequisite. This should not prevent the EU from considering sources from outside the EU if needed."

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP to remove 100 generic medicines from market

Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.

Further reading

Latest news

See all jobs